Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

In a pooled analysis of the SPARTAN and TITAN trials, statin use during apalutamide therapy was associated with superior overall survival (OS) but also with an increased risk for grade 3 or greater ...

PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Germany: A prognostic study published in JAMA Network Open suggests that the Bellmunt Risk Score (BRS) may help predict ...

Excess body weight, as measured by BMI, is associated with improved overall survival (OS) in men with advanced prostate cancer, particularly those with metastatic castration-resistant disease, a ...

Symptoms linked to urinary or sexual health often carry an element of embarrassment, making men less likely to discuss them ...

The nuclear medicine therapy targets prostate-specific membrane antigen (PSMA)-positive cancer cells, delivering radiation ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

Novartis launches Pluvicto, India's first approved radioligand therapy for advanced prostate cancer, enhancing precision ...